Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06121466 · ClinicalTrials.gov registry record · Phase 4
Effect of Abdominal Wall Injections on Abdominal Pain
A Phase 4 study of Anterior Cutaneous Nerve Entrapment Syndrome, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT06121466 is a Phase 4 study of Anterior Cutaneous Nerve Entrapment Syndrome that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 45 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT06121466, a Phase 4 study of Anterior Cutaneous Nerve Entrapment Syndrome, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.
Conditions Studied
Interventions
- DRUG Abdominal wall injections with lidocaine 2%
Study Locations (2)
Oregon
- OHSU - Portland
- Oregon Health Sciences University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06121466
The ClinicalTrials.gov registry entry for NCT06121466 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anterior Cutaneous Nerve Entrapment Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Abdominal wall injections with lidocaine 2% is the first listed.
NCT06121466 reports 2 study locations spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06121466 about?
NCT06121466 is a clinical study titled "Effect of Abdominal Wall Injections on Abdominal Pain". This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.
What is the current status of trial NCT06121466?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2023-01-01. Estimated completion is 2025-12.
What conditions does trial NCT06121466 study?
This clinical trial studies the following conditions: Anterior Cutaneous Nerve Entrapment Syndrome.
What interventions are being tested in trial NCT06121466?
The interventions under investigation include: Abdominal wall injections with lidocaine 2% (DRUG).
Who is sponsoring clinical trial NCT06121466?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06121466 being conducted?
This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.